Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VS-6063
VS-6063
Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Yahoo
Thu, 03/3/16 - 10:44 am
Merck
Pfizer
Verastem
ovarian cancer
clinical trials
avelumab
VS-6063
After two deaths, Verastem defends safety of experimental cancer drug
Bizjournals.com
Wed, 08/26/15 - 08:43 pm
Verastem
VS-6063
non-small cell lung cancer
Large U.S. cancer trial to match genetic glitches to targeted drugs
Yahoo/Reuters
Mon, 06/1/15 - 07:49 pm
clinical trials
Pfizer
Xalkori
Boehringer Ingelheim
Gilotrif
Roche
Kadcyla
AZD9291
AstraZeneca
VS-6063
Verastem
personalized medicine